Lisa Pham

Stay informed with Lisa Pham’s coverage and analysis for Fortune.

  • Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said on Wednesday its net profit jumped 21 percent in 2024 to 100 billion Danish kroner ($13.9 billion). Europe’s most valuable company said its sales rose 25 percent to 290.4 billion Danish kroner, propelled by its popular injections. (Photo by Mads Claus Rasmussen / Ritzau Scanpix / AFP) / Denmark OUT (Photo by MADS CLAUS RASMUSSEN/Ritzau Scanpix/AFP via Getty Images)Health

    Novo Nordisk overtakes SAP as Europe’s most valuable company

    By Lisa Pham and Bloomberg
  • Boxes of Lindt & Spruengli AG chocolates sit on display at a duty free store inside Zurich Airport, Switzerland on Saturday, Nov. 21, 2015. The franc is still too strong and the economy not yet back to full health, Swiss National Bank Governing Board member Andrea Maechler said. Photographer: Akos Stiller/Bloomberg via Getty ImagesRetail

    Swiss chocolate stocks diverge as high cocoa prices take toll

    By Allegra Catelli, Lisa Pham, and others
  • The decommissioned Isar 2 nuclear power plant is seen with greenery in the foreground.Environment

    The comeback of nuclear energy: Why asset managers are betting big

    By Lisa Pham and Bloomberg
  • Thomas Schinecker, CEO of Roche Holding.Retail

    An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value

    By Naomi Kresge, Lisa Pham, and others
  • LOS ANGELES, CALIFORNIA – APRIL 17: In this photo illustration, a box of the diabetes drug Ozempic rests on a pharmacy counter on April 17, 2023 in Los Angeles, California. Ozempic was originally approved by the FDA to treat people with Type 2 diabetes- who risk serious health consequences without medication. In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight loss benefits, which has led to shortages. Some doctors prescribe Ozempic off-label to treat obesity. (Photo illustration by Mario Tama/Getty Images)Health

    Fast-food outlets ‘are going to be hurt’ in areas where Ozempic and Wegovy are heavily used, but the selloff in candy and beer stocks is ‘somewhat overdone’

    By Lisa Pham, Dasha Afanasieva, and others
  • A customer browses gift wrapping supplies displayed for sale at a Dollar Tree Inc. store in Louisville, Kentucky, U.S., on Friday, Aug. 24, 2018. Dollar Tree Inc. is scheduled to release earnings figures on August 30. Photographer: Luke Sharrett/Bloomberg via Getty ImagesRetail

    If you thought the tech rout was bad, spare a dime for retailers: Consumers are ‘trading down in lunch meats due to inflation’

    By Thyagaraju Adinarayan, Lisa Pham, and others
  • Shadow of airplane over forest and a lakeEnvironment

    Here’s how many trees you should plant if you’re feeling guilty about your next vacation

    By Lisa Pham and Bloomberg